TÜRKÇE
ENGLISH
Information
| Code | ECS311 |
| Name | Microbiota |
| Term | 2024-2025 Academic Year |
| Semester | 5. Semester |
| Duration (T+A) | 2-0 (T-A) (17 Week) |
| ECTS | 2 ECTS |
| National Credit | 2 National Credit |
| Teaching Language | Türkçe |
| Level | Belirsiz |
| Type | Normal |
| Label | E Elective |
| Mode of study | Yüz Yüze Öğretim |
| Catalog Information Coordinator | Suna KIZILYILDIRIM |
| Course Instructor |
Suna KIZILYILDIRIM
(A Group)
(Ins. in Charge)
|
Course Goal / Objective
It aims to teach the definition of microbiota, its effects on human health, the importance of nutrition in microbiota, and the relationships between microbiota and diseases.
Course Content
Relationship between prebiotics, vitamins, minerals and microbiota
Course Precondition
There are no prerequisites
Resources
Sophie A. Montandon and François R. Jornayvaz.Effects of Antidiabetic Drugs on Gut Microbiota Composition. Genes 2017, 8, 250; doi:10.3390/genes8100250. The Role of Gut Microbiota on Obesity Development. Dina Anatolievna Lavrenkov September, 2013.
Notes
Elizabeth Thursby and Nathalie Juge. Introduction to the human gut microbiota. Biochemical Journal (2017) 474 1823–1836.
Course Learning Outcomes
| Order | Course Learning Outcomes |
|---|---|
| LO01 | Gains information about microbiota. |
| LO02 | It can explain the factors affecting the microbiota. |
| LO03 | Gain an idea about the importance of early infancy nutrition in microbiota. |
| LO04 | It may explain the relationship between microbiota and metabolic diseases. |
| LO05 | It may explain the relationship between microbiota and other diseases. |
Relation with Program Learning Outcome
| Order | Type | Program Learning Outcomes | Level |
|---|---|---|---|
| PLO01 | Bilgi - Kuramsal, Olgusal | Have sufficient knowledge in pharmaceutical field and develop the knowledge. | 1 |
| PLO02 | Bilgi - Kuramsal, Olgusal | Comprehends professional knowledge with ethical responsibility through current laws and legislation. | 2 |
| PLO03 | Beceriler - Bilişsel, Uygulamalı | Provides consultancy service to patients, community and health care personnel and evaluates advanced knowledge and skills with a critical approach. | 1 |
| PLO04 | Beceriler - Bilişsel, Uygulamalı | Possessing the knowledge of historical and current developments in the field of Pharmacy, monitoring, evaluation and application of scientific and evidence-based data, and adopting lifelong learning. | 3 |
| PLO05 | Beceriler - Bilişsel, Uygulamalı | Have the knowledge and skills to help provide patient-oriented pharmacy applications and individualized pharmaceutical care by learning the basics of Clinical Pharmacy, | 4 |
| PLO06 | Yetkinlikler - Bağımsız Çalışabilme ve Sorumluluk Alabilme Yetkinliği | Takes a role in the evaluation and analysis of the events and cases related to the development of pharmacy profession and education. | |
| PLO07 | Yetkinlikler - Öğrenme Yetkinliği | Integrates and develops professional knowledge via different disciplines and uses the acquired knowledge to improve the health level and quality of life of the community. | |
| PLO08 | Yetkinlikler - Öğrenme Yetkinliği | Use effectively the concepts and applications of basic sciences and basic medical sciences in the field of medicine and pharmacy and update the information. | 3 |
| PLO09 | Yetkinlikler - İletişim ve Sosyal Yetkinlik | Communicates effectively in writing and speaking. | |
| PLO10 | Yetkinlikler - İletişim ve Sosyal Yetkinlik | Practices the profession in accordance with Atatürk's principles and reforms, equipped with universal knowledge, uses Turkish correctly and knows at least one foreign language. | 2 |
| PLO11 | Yetkinlikler - İletişim ve Sosyal Yetkinlik | Be an example to society withexternal appearance, demeanor, attitude and behavior for the other professionals and society and with professional identity | 2 |
| PLO12 | Yetkinlikler - Alana Özgü Yetkinlik | Have knowledge about health policies and health economics, pharmacy management and define the problems in pharmaceutical field. | 3 |
| PLO13 | Yetkinlikler - Alana Özgü Yetkinlik | Interprets information about current health and treatment problems and attends meeting on related matters . Plays an active role in community health. | 4 |
| PLO14 | Yetkinlikler - Alana Özgü Yetkinlik | Acquires basic information about diseases, makes decisions about the drugs used in treatment in accordance with rational drug use. | 5 |
Week Plan
| Week | Topic | Preparation | Methods |
|---|---|---|---|
| 1 | Introduction to microbiota | Lecture notes | |
| 2 | General donation to the relationship between health and microbiota | Lecture notes | |
| 3 | The relationship between nutrition and microbiota | Lecture notes | |
| 4 | Infancy nutrition and its importance in mycobiota | Lecture notes | |
| 5 | Effects of different nutritional models on intestinal microbiota | Lecture notes | |
| 6 | Prebiotics, probiotics | Lecture notes | |
| 7 | Postbiotics in the microbiota | Lecture notes | |
| 8 | Mid-Term Exam | Lecture notes | |
| 9 | Vitamins and Minerals in Microbiota | Lecture notes | |
| 10 | Microbiota and metabolic diseases | Lecture notes | |
| 11 | Microbiota-inflammation relationship | Lecture notes | |
| 12 | Microbiota and cardiovascular diseases | Lecture notes | |
| 13 | Microbiota and cancer | Lecture notes | |
| 14 | Molecular diagnostic methods in microbiota applications-1 | Lecture notes | |
| 15 | Molecular diagnostic methods in microbiota applications-2 | Lecture notes | |
| 16 | Term Exams | Lecture notes | |
| 17 | Term Exams | Lecture notes |
Student Workload - ECTS
| Works | Number | Time (Hour) | Workload (Hour) |
|---|---|---|---|
| Course Related Works | |||
| Class Time (Exam weeks are excluded) | 14 | 2 | 28 |
| Out of Class Study (Preliminary Work, Practice) | 14 | 2 | 28 |
| Assesment Related Works | |||
| Homeworks, Projects, Others | 0 | 0 | 0 |
| Mid-term Exams (Written, Oral, etc.) | 1 | 2 | 2 |
| Final Exam | 1 | 4 | 4 |
| Total Workload (Hour) | 62 | ||
| Total Workload / 25 (h) | 2,48 | ||
| ECTS | 2 ECTS | ||